|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ciencewicki J, Trivedi S and Kleeberger
SR: Oxidants and the pathogenesis of lung diseases. J Allergy Clin
Immunol. 122:456–468, 469-470. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ghio AJ, Carraway MS and Madden MC:
Composition of air pollution particles and oxidative stress in
cells, tissues, and living systems. J Toxicol Environ Health B Crit
Rev. 15:1–21. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Höhn A, Jung T and Grune T:
Pathophysiological importance of aggregated damaged proteins. Free
Radic Biol Med. 71:70–89. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Barouki R: Ageing free radicals and
cellular stress. Med Sci (Paris). 22:266–272. 2006.(In French).
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ziech D, Franco R, Georgakilas AG,
Georgakila S, Malamou-Mitsi V, Schoneveld O, Pappa A and
Panayiotidis MI: The role of reactive oxygen species and oxidative
stress in environmental carcinogenesis and biomarker development.
Chem Biol Interact. 188:334–339. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kryston TB, Georgiev AB, Pissis P and
Georgakilas AG: Role of oxidative stress and DNA damage in human
carcinogenesis. Mutat Res. 711:193–201. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reuter S, Gupta SC, Chaturvedi MM and
Aggarwal BB: Oxidative stress, inflammation, and cancer: How are
they linked? Free Radic Biol Med. 49:1603–1616. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kardeh S, Ashkani-Esfahani S and Alizadeh
AM: Paradoxical action of reactive oxygen species in creation and
therapy of cancer. Eur J Pharmacol. 735:150–168. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Azimi I, Petersen RM, Thompson EW,
Roberts-Thomson SJ and Monteith GR: Hypoxia-induced reactive oxygen
species mediate N-cadherin and SERPINE1 expression, EGFR signalling
and motility in MDA-MB-468 breast cancer cells. Sci Rep.
7:151402017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chiarugi P, Pani G, Giannoni E, Taddei L,
Colavitti R, Raugei G, Symons M, Borrello S, Galeotti T and Ramponi
G: Reactive oxygen species as essential mediators of cell adhesion:
The oxidative inhibition of a FAK tyrosine phosphatase is required
for cell adhesion. J Cell Biol. 161:933–944. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Poillet-Perez L, Despouy G,
Delage-Mourroux R and Boyer-Guittaut M: Interplay between ROS and
autophagy in cancer cells, from tumor initiation to cancer therapy.
Redox Biol. 4:184–192. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Itkonen O and Stenman UH: TATI as a
biomarker. Clin Chim Acta. 431:260–269. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stenman UH: Role of the tumor-associated
trypsin inhibitor SPINK1 in cancer development. Asian J Androl.
13:628–629. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Räsänen K, Itkonen O, Koistinen H and
Stenman UH: Emerging Roles of SPINK1 in Cancer. Clin Chem.
62:449–457. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stenman UH: SPINK1: A new therapeutic
target in cancer? Clin Chem. 57:1474–1475. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiao F, Hu H, Han T, Zhuo M, Yuan C, Yang
H and Wang L and Wang L: Aberrant expression of nuclear HDAC3 and
cytoplasmic CDH1 predict a poor prognosis for patients with
pancreatic cancer. Oncotarget. 7:16505–16516. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peirson SN, Butler JN and Foster RG:
Experimental validation of novel and conventional approaches to
quantitative real-time PCR data analysis. Nucleic Acids Res.
31:e732003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kwak MK, Kensler TW and Casero RJ Jr:
Induction of phase 2 enzymes by serum oxidized polyamines through
activation of Nrf2: Effect of the polyamine metabolite acrolein.
Biochem Biophys Res Commun. 305:662–670. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kong H and Chandel NS: Regulation of redox
balance in cancer and T cells. J Biol Chem. 293:7499–7507. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liang C, Shi S, Liu M, Qin Y, Meng Q, Hua
J, Ji S, Zhang Y, Yang J, Xu J, et al: PIN1 maintains redox balance
via the c-Myc/NRF2 axis to counteract Kras-induced mitochondrial
respiratory injury in pancreatic cancer cells. Cancer Res.
79:133–145. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Masamune A, Mizutamari H, Kume K, Asakura
T, Satoh K and Shimosegawa T: Hereditary pancreatitis as the
premalignant disease: A Japanese case of pancreatic cancer
involving the SPINK1 gene mutation N34S. Pancreas. 28:305–310.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ohmuraya M, Hirota M, Araki M, Mizushima
N, Matsui M, Mizumoto T, Haruna K, Kume S, Takeya M, Ogawa M, et
al: Autophagic cell death of pancreatic acinar cells in serine
protease inhibitor Kazal type 3-deficient mice. Gastroenterology.
129:696–705. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ying HY, Gong CJ, Feng Y, Jing DD and Lu
LG: Serine protease inhibitor Kazal type 1 (SPINK1) downregulates
E-cadherin and induces EMT of hepatoma cells to promote
hepatocellular carcinoma metastasis via the MEK/ERK signaling
pathway. J Dig Dis. 18:349–358. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gaber A, Stene C, Hotakainen K, Nodin B,
Palmquist I, Bjartell A, Stenman UH, Jeppsson B, Johnson LB and
Jirström K: Effects of radiation therapy on tissue and serum
concentrations of tumour associated trypsin inhibitor and their
prognostic significance in rectal cancer patients. Radiat Oncol.
6:1002011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Moloney JN and Cotter TG: ROS signalling
in the biology of cancer. Semin Cell Dev Biol. 80:50–64. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Prasad S, Gupta SC and Tyagi AK: Reactive
oxygen species (ROS) and cancer: Role of antioxidative
nutraceuticals. Cancer Lett. 387:95–105. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bapat S, Verkleij A and Post JA:
Peroxynitrite activates mitogen-activated protein kinase (MAPK) via
a MEK- independent pathway: A role for protein kinase C. Febs Lett.
499:21–26. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Farrukh MR, Nissar UA, Afnan Q, Rafiq RA,
Sharma L, Amin S, Kaiser P, Sharma PR and Tasduq SA: Oxidative
stress mediated Ca(2+) release manifests endoplasmic reticulum
stress leading to unfolded protein response in UV-B irradiated
human skin cells. J Dermatol Sci. 75:24–35. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Panayiotidis M: Reactive oxygen species
(ROS) in multistage carcinogenesis. Cancer Lett. 266:3–5. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Miller JH, Jin S, Morgan WF, Yang A, Wan
Y, Aypar U, Peters JS and Springer DL: Profiling mitochondrial
proteins in radiation-induced genome-unstable cell lines with
persistent oxidative stress by mass spectrometry. Radiat Res.
169:700–706. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zong WX, Rabinowitz JD and White E:
Mitochondria and cancer. Mol Cell. 61:667–676. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen J, Zhang L, Yu X, Zhou H, Luo Y, Wang
W and Wang L: Clinical application of plasma mitochondrial DNA
content in patients with lung cancer. Oncol Lett. 16:7074–7081.
2018.PubMed/NCBI
|
|
37
|
Sansone P, Savini C, Kurelac I, Chang Q,
Amato LB, Strillacci A, Stepanova A, Iommarini L, Mastroleo C, Daly
L, et al: Packaging and transfer of mitochondrial DNA via exosomes
regulate escape from dormancy in hormonal therapy-resistant breast
cancer. Proc Natl Acad Sci USA. 114:E9066–E9075. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lin CS, Liu LT, Ou LH, Pan SC, Lin CI and
Wei YH: Role of mitochondrial function in the invasiveness of human
colon cancer cells. Oncol Rep. 39:316–330. 2018.PubMed/NCBI
|
|
39
|
DeGraff WG, Krishna MC, Kaufman D and
Mitchell JB: Nitroxide-mediated protection against X-ray- and
neocarzinostatin-induced DNA damage. Free Radic Biol Med.
13:479–487. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhou D, Shao L and Spitz DR: Reactive
oxygen species in normal and tumor stem cells. Adv Cancer Res.
122:1–67. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yu J, Sun W, Song Y, Liu J, Xue F, Gong K,
Yang X and Kang Q: SIRT6 protects retinal ganglion cells against
hydrogen peroxide-induced apoptosis and oxidative stress by
promoting Nrf2/ARE signaling via inhibition of Bach1. Chem Biol
Interact. 300:151–158. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sajadimajd S and Khazaei M: Oxidative
stress and cancer: The role of Nrf2. Curr Cancer Drug Targets.
18:538–557. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Deshmukh P, Unni S, Krishnappa G and
Padmanabhan B: The Keap1-Nrf2 pathway: Promising therapeutic target
to counteract ROS-mediated damage in cancers and neurodegenerative
diseases. Biophys Rev. 9:41–56. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Taguchi K and Yamamoto M: The KEAP1-NRF2
system in cancer. Front Oncol. 7:852017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hayes AJ, Skouras C, Haugk B and Charnley
RM: Keap1-Nrf2 signalling in pancreatic cancer. Int J Biochem Cell
Biol. 65:288–299. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ozaki N, Ohmuraya M, Hirota M, Ida S, Wang
J, Takamori H, Higashiyama S, Baba H and Yamamura K: Serine
protease inhibitor Kazal type 1 promotes proliferation of
pancreatic cancer cells through the epidermal growth factor
receptor. Mol Cancer Res. 7:1572–1581. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang C, Wang L, Su B, Lu N, Song J, Yang
X, Fu W, Tan W and Han B: Serine protease inhibitor Kazal type 1
promotes epithelial-mesenchymal transition through EGFR signaling
pathway in prostate cancer. Prostate. 74:689–701. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen YT, Tsao SC, Yuan SS, Tsai HP and
Chai CY: Serine protease inhibitor Kazal type 1 (SPINK1) promotes
proliferation of colorectal cancer through the epidermal growth
factor as a prognostic marker. Pathol Oncol Res. 21:1201–1208.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ateeq B, Tomlins SA, Laxman B, Asangani
IA, Cao Q, Cao X, Li Y, Wang X, Feng FY, Pienta KJ, et al:
Therapeutic targeting of SPINK1-positive prostate cancer. Sci
Transl Med. 3:72ra172011. View Article : Google Scholar : PubMed/NCBI
|
